Page last updated: 2024-08-25

5-hydroxymethylcytosine and Cancer of Ovary

5-hydroxymethylcytosine has been researched along with Cancer of Ovary in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Chiang, CY; Daifotis, HA; Fahrmann, JF; Fiehn, O; Lastra, RR; Lengyel, E; Mukherjee, A; Nieman, KM; Romero, IL1
Dinulescu, DM; Getchell, CR; Gupta, M; Hasselblatt, KT; Hirsch, MS; Kaplan, SJ; Ko, JY; Lee, JJ; Li, W; Lian, CG; Liu, JF; MacDonald, LA; Malik, A; Matulonis, UA; McCarthy, ET; Medina, JE; Murphy, GF; Ohman, AW; Sasamoto, N; Shafrir, A; Terry, KL; Tucker, DW; Xu, S; Zhang, H1
Li, PL; Wang, TZ; Zhang, LY; Zhang, XC1

Other Studies

3 other study(ies) available for 5-hydroxymethylcytosine and Cancer of Ovary

ArticleYear
Adipocyte-Induced FABP4 Expression in Ovarian Cancer Cells Promotes Metastasis and Mediates Carboplatin Resistance.
    Cancer research, 2020, 04-15, Volume: 80, Issue:8

    Topics: 5-Methylcytosine; Adipocytes; Animals; Antineoplastic Agents; Biphenyl Compounds; Carboplatin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Clustered Regularly Interspaced Short Palindromic Repeats; Coculture Techniques; DNA Methylation; Down-Regulation; Drug Resistance, Neoplasm; Fatty Acid-Binding Proteins; Female; Gene Knockdown Techniques; Heterografts; Humans; Lipid Metabolism; Lipidomics; Mass Spectrometry; Metabolomics; Mice; Mice, Nude; Neoplasm Metastasis; Neoplasm Proteins; Omentum; Ovarian Neoplasms; Protein Array Analysis; Proteomics; Pyrazoles; Tumor Burden; Up-Regulation

2020
Epigenetic Reprogramming Strategies to Reverse Global Loss of 5-Hydroxymethylcytosine, a Prognostic Factor for Poor Survival in High-grade Serous Ovarian Cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2018, 03-15, Volume: 24, Issue:6

    Topics: 5-Methylcytosine; Animals; Cell Survival; Cellular Reprogramming; Combined Modality Therapy; Cystadenocarcinoma, Serous; Dioxygenases; Disease Models, Animal; Disease Progression; DNA Methylation; DNA-Binding Proteins; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Neoplasm Grading; Ovarian Neoplasms; Prognosis; Proto-Oncogene Proteins; Recurrence; Survival Analysis; Xenograft Model Antitumor Assays

2018
Prognostic values of 5-hmC, 5-mC and TET2 in epithelial ovarian cancer.
    Archives of gynecology and obstetrics, 2015, Volume: 292, Issue:4

    Topics: 5-Methylcytosine; Adult; Aged; Biomarkers, Tumor; Carcinoma, Ovarian Epithelial; Case-Control Studies; Cytosine; Dioxygenases; DNA Methylation; DNA-Binding Proteins; Female; Humans; Immunohistochemistry; Lymphatic Metastasis; Middle Aged; Neoplasm Grading; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Prognosis; Proto-Oncogene Proteins; Survival Analysis

2015